Enhanced therapeutic efficacy of sequential ¹⁷⁷Lu/²²⁵Ac-LNC1004 FAP-targeted radionuclide therapy combined with anti–PD-L1 blockade in pancreatic cancer
本文未提供摘要,请点击“查看全文”查看完整内容。